Drug Shortage Report for SANDOZ LOSARTAN HCT

Last updated on 2018-07-03 History
Report ID 44734
Drug Identification Number 02362449
Brand name SANDOZ LOSARTAN HCT
Common or Proper name LOSARTAN Hydrochlorothiazide
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM
Strength(s) 12.5MG 100MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 TABLETS
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-03-23
Estimated end date 2018-05-31
Actual end date 2018-06-14
Shortage status Resolved
Updated date 2018-07-03
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2018-07-03 French Compare
v7 2018-07-03 English Compare
v6 2018-05-23 French Compare
v5 2018-05-23 English Compare
v4 2018-04-03 French Compare
v3 2018-04-03 English Compare
v2 2018-04-03 French Compare
v1 2018-04-03 English Compare